Background: Continuous low-intensity ultrasound (cLIUS) facilitates the chondrogenic differentiation of human mesenchymal stromal cells (MSCs) in the absence of exogenously added transforming growth factor-beta (TGFβ) by upregulating the expression of transcription factor SOX9, a master regulator of chondrogenesis. The present study evaluated the molecular events associated with the signaling pathways impacting SOX9 gene and protein expression under cLIUS.Methods: Human bone marrow-derived MSCs were exposed to cLIUS stimulation at 14 kPa (5 MHz, 2.5 Vpp) for 5 min. The gene and protein expression of SOX9 was evaluated. The specificity ofSOX9upregulation under cLIUS was determined by treating the MSCs with small molecule inhibitors of select signaling molecules, followed by cLIUS treatment. Signaling events regulatingSOX9expression under cLIUS were analyzed by gene expression, immunofluorescence staining, and western blotting.Results: cLIUS upregulated the gene expression ofSOX9and enhanced the nuclear localization of SOX9 protein when compared to non-cLIUS-stimulated control. cLIUS was noted to enhance the phosphorylation of the signaling molecule ERK1/2. Inhibition of MEK/ERK1/2 by PD98059 resulted in the effective abrogation of cLIUS-inducedSOX9expression, indicating that cLIUS-inducedSOX9upregulation was dependent on the phosphorylation of ERK1/2. Inhibition of integrin and TRPV4, the upstream cell-surface effectors of ERK1/2, did not inhibit the phosphorylation of ERK1/2 and therefore did not abrogate cLIUS-inducedSOX9expression, thereby suggesting the involvement of other mechanoreceptors. Consequently, the effect of cLIUS on the actin cytoskeleton, a mechanosensitive receptor regulatingSOX9, was evaluated. Diffused and disrupted actin fibers observed in MSCs under cLIUS closely resembled actin disruption by treatment with cytoskeletal drug Y27632, which is known to increase the gene expression ofSOX9. The upregulation ofSOX9under cLIUS was, therefore, related to cLIUS-induced actin reorganization.SOX9upregulation induced by actin reorganization was also found to be dependent on the phosphorylation of ERK1/2.Conclusions: Collectively, preconditioning of MSCs by cLIUS resulted in the nuclear localization of SOX9, phosphorylation of ERK1/2 and disruption of actin filaments, and the expression ofSOX9was dependent on the phosphorylation of ERK1/2 under cLIUS.
Cartilage repair outcomes are compromised in a pro-inflammatory environment; therefore, the mitigation of pro-inflammatory responses is beneficial. Treatment with continuous low-intensity ultrasound (cLIUS) at the resonant frequency of 5 MHz is proposed for the repair of chondral fissures under pro-inflammatory conditions. Bovine osteochondral explants, concentrically incised to create chondral fissures, were maintained under cLIUS (14 kPa (5 MHz, 2.5 Vpp), 20 min, 4 times/day) for a period of 28 days in the presence or absence of cytokines, interleukin-6 (IL-6) or tumor necrosis factor (TNF)α. Outcome assessments included histological and immunohistochemical staining of the explants; and the expression of catabolic and anabolic genes by qRT-PCR in bovine chondrocytes. Cell migration was assessed by scratch assays, and by visualizing migrating cells into the hydrogel core of cartilage-hydrogel constructs. Both in the presence and absence of cytokines, higher percent apposition along with closure of fissures were noted in cLIUS-stimulated explants as compared to non-cLIUS-stimulated explants on day 14. On day 28, the percent apposition was not significantly different between unstimulated and cLIUS-stimulated explants exposed to cytokines. As compared to non-cLIUS-stimulated controls, on day 28, cLIUS preserved the distribution of proteoglycans and collagen II in explants despite exposure to cytokines. cLIUS enhanced the cell migration irrespective of cytokine treatment. IL-6 or TNFα-induced increases in MMP13 and ADAMTS4 gene expression was rescued by cLIUS stimulation in chondrocytes. Under cLIUS, TNFα-induced increase in NF-κB expression was suppressed, and the expression of collagen II and TIMP1 genes were upregulated. cLIUS repaired chondral fissures, and elicited pro-anabolic and anti-catabolic effects, thus demonstrating the potential of cLIUS in improving cartilage repair outcomes.
Proinflammatory joint environment, coupled with impeded chondrogenic differentiation of mesenchymal stromal cells (MSCs), led to inferior cartilage repair outcomes. Nuclear translocation of phosphorylated-NFκB downregulates SOX9 and hinders the chondrogenesis of MSCs. Strategies that minimize the deleterious effects of NFκB, while promoting MSC chondrogenesis, are of interest. This study establishes the ability of continuous low-intensity ultrasound (cLIUS) to preserve MSC chondrogenesis in a proinflammatory environment. MSCs were seeded in alginate:collagen hydrogels and cultured for 21 days in an ultrasound-assisted bioreactor (5.0 MHz, 2.5 Vpp; 4 applications/day) in the presence of IL1β and evaluated by qRT-PCR and immunofluorescence. The differential expression of markers associated with the NFκB pathway was assessed upon a single exposure of cLIUS and assayed by Western blotting, qRT-PCR, and immunofluorescence. Mitochondrial potential was evaluated by tetramethylrhodamine methyl ester (TMRM) assay. The chondroinductive potential of cLIUS was noted by the increased expression of SOX9 and COLII. cLIUS extended its chondroprotective effects by stabilizing the NFκB complex in the cytoplasm via engaging the IκBα feedback mechanism, thus preventing its nuclear translocation. cLIUS acted as a mitochondrial protective agent by restoring the mitochondrial potential and the mitochondrial mRNA expression in a proinflammatory environment. Altogether, our results demonstrated the potential of cLIUS for cartilage repair and regeneration under proinflammatory conditions.
4 December 2025 in Frontiers in Bioengineering and Biotechnology
Post-traumatic osteoarthritis (PTOA), a subtype of osteoarthritis initiated by joint trauma, is driven by unresolved early inflammation that ultimately leads to cartilage degeneration. Although animal models have advanced our understanding of disease progression, they offer limited resolution of the early molecular events following trauma. In this study, we developed a transwell-based in vitro triculture model mimicking the early joint environment post-injury, incorporating macrophages, fibroblast-like synoviocytes (FLSs), and human articular chondrocytes (HACs). In lieu of the commonly used macrophage activator, lipopolysaccharide (LPS), this study utilizes fibronectin fragments (Fnfs), which belong to the damage-associated molecules released upon trauma to cartilage, to activate macrophages and simulate post-traumatic inflammation. The triculture was maintained for 12 days while promoting paracrine-only communication between the cell types. The activation of macrophages by Fnfs led to a sustained expression of pNFκB in both HACs and FLSs, as shown by immunofluorescence, alongside increased gene expression of inflammatory mediators MMP3, MMP13, and TNF-α. Fnfs triggered catabolic signaling across all joint-resident cell types used in this model. To support the translational relevance of the in vitro findings, a complementary in vivo experiment in which Fnfs were injected intra-articularly showed increased MMP activity gene expression and reduced COL2A1 gene expression in joint cartilage. The cytokine and gene expression profiles observed in the triculture model closely mirrored those observed in early-stage in vivo PTOA models and in the patient-derived synovial fluid obtained in the early traumatic phase, underscoring the model’s physiological relevance. This triculture platform captures the key aspects of early PTOA processes driven by macrophage activation and offers a biologically relevant tool for mechanistic studies and therapeutic screening.
8 November 2022 in Journal of Biomechanical Engineering
Low-intensity ultrasound has shown promise in promoting the healing and regeneration of cartilage degraded by osteoarthritis. In this study, a 2-D finite element method (FEM) model was developed for solving the Biot theory equations governing the propagation of continuous ultrasound through cartilage. Specifically, we compute the ultrasound-induced dilatations and displacements in microscale cartilage that is represented as consisting of four zones, namely the chondrocyte cell and its nucleus, the pericellular matrix (PCM) that forms a layer around the chondrocyte, and the extracellular matrix (ECM). The chondrocyte–PCM complex, referred to as the chondron, is embedded in the ECM. We model multiple cartilage configurations wherein the ECM layer contains chondrons along the depth, as well as laterally. The top surface of ECM layer is subjected to specified amplitude and frequency of continuous ultrasound. The resulting wave propagation is modeled by numerically solving the 2-D Biot equations for seven frequencies in the 0.5~MHz to 5~MHz range. It is seen that ultrasound is attenuated in the ECM and the attenuation increases monotonically with frequency. In contrast, manyfold augmentation of ultrasound amplitudes is observed inside the cytoplasm and nucleus of the chondrocyte. Chondrocytes act as a major sink of ultrasound energy, thereby reducing the depthwise propagation of ultrasound fluctuations. Regions of high dilatations and displacements were found at the ECM–PCM interface, PCM–chondrocyte interace, as well as in the cytoplasm and nucleus.
Objective: Dysregulation of the anabolic processes in a proinflammatory joint environment coupled with impeded chondrogenic differentiation of mesenchymal stromal cells (MSCs) led to inferior cartilage repair outcomes. The preponderance of proinflammatory cytokines activated nuclear factor kappa B (NFκB) and impeded the chondrogenesis of MSCs. Thus, strategies that minimize the deleterious effects of activated NFκB while promoting MSC chondrogenesis are of interest. The present study establishes the ability of continuous low-intensity ultrasound (cLIUS) to rescue MSC chondrogenesis impacted by a proinflammatory environment. Methods: Human bone marrow-derived MSCs were seeded in alginate:collagen hydrogels and cultured for 21-days in an ultrasound-assisted bioreactor 14 kPa (5.0 MHz, 2.5 Vpp; 4-applications/day) for 21 days in the presence of IL1β and evaluated by qRT-PCR (n=10), immunofluorescence (n=15), western blotting (WB) (n=6), and immunohistochemistry (n=3). The differential expression of markers associated with NFκB pathway under cLIUS were evaluated upon a single exposure of cLIUS and assayed by qRT-PCR (n=3), immunofluorescence (n=30-60), WB (n=6) and tetramethylrhodamine methyl ester assay (n=50) was used to assess the mitochondrial potential under IL1β and cLIUS treatment.Results: Chondroinductive potential of cLIUS was preserved as noted by the increased expression of SOX9 and deposition of collagen II. cLIUS extended its chondroprotective effects by stabilizing the NFκB complex in the cytoplasm via engaging the IκBα feedback mechanism, thus preventing its nuclear translocation. cLIUS acted as a mitochondrial protective agent by restoring the mitochondrial potential and the mitochondrial mRNA expression in a proinflammatory environment. Conclusion: Our results demonstrated the potential of cLIUS for cartilage repair and regeneration under proinflammatory conditions.